Gerard W.M. Visser

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine

Maria J.W.D. Vosjan, Lars R. Perk, Gerard W.M. Visser et al. · Nature Protocols · 2010 · 440 citations

Medicine, Nuclear Medicine, Radiology +14

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Iris Verel, Gerard W.M. Visser, Ronald Boellaard et al. · PubMed · 2003 · 370 citations

Pharmacy, Biotechnology, Immunology +17

Basic principles, applications in oncology and improved selectivity of photodynamic therapy.

Maarten B. Vrouenraets, Gerard W.M. Visser, Gordon B. Snow et al. · PubMed · 2003 · 314 citations

Medicine, Oncology, Pharmacology +13

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

Lars R. Perk, Maria J.W.D. Vosjan, Gerard W.M. Visser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 215 citations · Full text

Medicine, Immunology, Nuclear Medicine +17

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Lars R. Perk, Gerard W.M. Visser, Maria J.W.D. Vosjan et al. · PubMed · 2005 · 205 citations

Medicine, Nuclear Medicine, Oncology +17